Aegerion Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Aegerion Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2005. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2010.
Aegerion Pharmaceuticals at a glance
What does Aegerion Pharmaceuticals do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $18.3 million sold (2010).
Frequently asked questions about Aegerion Pharmaceuticals
Where is Aegerion Pharmaceuticals headquartered?
Aegerion Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Aegerion Pharmaceuticals do?
Aegerion Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Aegerion Pharmaceuticals founded?
The earliest incorporation on record for Aegerion Pharmaceuticals, Inc. is in 2005, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.